Tuesday, May 21, 2013

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Tue, May 21)

Tuesday, May 14, 2013

• IMPRIMIS PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials (Tue, May 14)

Wednesday, May 8, 2013

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Wed, May 8)
• Imprimis Rising: Unique Pathway Requires Fewer and Smaller Clinical TrialsMarketwired (Wed, May 8)

Thursday, April 18, 2013

• Imprimis Pharmaceuticals, Inc. Concludes Type C Meeting at the FDAPR Newswire (Thu, Apr 18)

Friday, April 12, 2013

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Fri, Apr 12)

Thursday, April 11, 2013

• 2 Biotech Stocks Under $10 to Watchat TheStreet (Thu, Apr 11)

Monday, March 18, 2013

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 10-K, Annual ReportEDGAR Online (Mon, Mar 18)

Wednesday, March 13, 2013

• Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment OptionPR Newswire (Wed, Mar 13)

Monday, March 4, 2013

• Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical ProductsPR Newswire (Mon, Mar 4)

Thursday, February 21, 2013

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements aEDGAR Online (Thu, Feb 21)

Tuesday, February 19, 2013

• Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAIDPR Newswire (Tue, Feb 19)

Friday, February 8, 2013

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of EEDGAR Online (Fri, Feb 8)

Thursday, February 7, 2013

• Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common StockPR Newswire (Thu, Feb 7)

Tuesday, December 18, 2012

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Tue, Dec 18)

Wednesday, November 14, 2012

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Wed, Nov 14)

Friday, August 31, 2012

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of EEDGAR Online (Fri, Aug 31)

Tuesday, August 14, 2012

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Aug 14)

Friday, July 27, 2012

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors orEDGAR Online (Fri, Jul 27)

Tuesday, July 24, 2012

• IMPRIMIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors orEDGAR Online (Tue, Jul 24)

Add IMMY News to My Yahoo!